• 1
    Brightling CE, Bradding P, Pavord ID, Wardlaw AJ. New insights into the role of the mast cell in asthma. Clin Exp Allergy 2003; 33:5506.
  • 2
    Boyce JA. The role of mast cells in asthma. Prostaglandins Leukot Essent Fatty Acids 2003; 69:195205.
  • 3
    Maezawa Y, Nakajima H, Seto Y et al. IgE-dependent enhancement of Th2 cell-mediated allergic inflammation in the airways. Clin Exp Immunol 2004; 135:1218.
  • 4
    Djukanovic R, Wilson SJ, Kraft M et al. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med 2004; 170:58393.
  • 5
    Bradding P, Roberts JA, Britten KM et al. Interleukin-4, -5 and -6 and tumour necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10:47180.
  • 6
    Shakoory B, Fitzgerald SM, Lee SA, Chi DS, Krishnaswamy G. The role of human mast cell-derived cytokines in eosinophil biology. J Interferon Cytokine Res 2004; 24:27181.
  • 7
    Dahlen SE, Kumlin M. Monitoring mast cell activation by prostaglandin D2in vivo. Thorax 2004; 59:4535.
  • 8
    Murray JJ, Tonnel AB, Brash AR et al. Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med 1986; 315:8004.
  • 9
    Giles H, Leff P, Bolofo ML, Kelly MG, Robertson AD. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. Br J Pharmacol 1989; 96:291300.
  • 10
    Hirai H, Tanaka K, Yoshie O et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001; 193:25561.
  • 11
    Raible DG, Schulman ES, DiMuzio J, Cardillo R, Post TJ. Mast cell mediators prostaglandin D2 and histamine activate human eosinophils. J Immunol 1992; 148:353642.
  • 12
    Nagata K, Hirai H, Tanaka K et al. CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s). FEBS Lett 1999; 459:1959.
  • 13
    Xue L, Gyles SL, Wettey FR, Gazi L, Townsend E, Hunter MG, Pettipher R. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on Chemoattractant Receptor expressed on Th2 cells. J Immunol 2005; 175:65316.
  • 14
    McKenniff MG, Norman P, Cuthbert NJ, Gardiner PJ. BAY u3405, a potent and selective thromboxane A2 receptor antagonist on airway smooth muscle in vitro. Br J Pharmacol 1991; 104:58590.
  • 15
    Sugimoto H, Shichijo M, Iino T et al. An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro. J Pharmacol Exp Ther 2003; 305:34752.
  • 16
    Nakahata T, Toru H. Cytokines regulate development of human mast cells from hematopoietic progenitors. Int J Hematol 2002; 75:3506.
  • 17
    Craig SS, Schwartz LB. Tryptase and chymase, markers of distinct types of human mast cells. Immunol Res 1989; 8:13048.
  • 18
    Gazi L, Gyles S, Rose J et al. Delta12-prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes. Prostaglandins Other Lipid Med 2005; 75:15367.
  • 19
    Lewis RA, Soter NA, Diamond PT, Austen KF, Oates JA, Roberts LJ 2nd. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 1982; 129:162731.
  • 20
    Kawata R, Reddy ST, Wolner B, Herschman HR. Prostaglandin synthase 1 and prostaglandin synthase 2 both participate in activation-induced prostaglandin D2 production in mast cells. J Immunol 1995; 155:81825.
  • 21
    De Paulis A, Ciccarelli A, Marino I, De Crescenzo G, Marino D, Marone G. Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs. Arthr Rheum 1997; 40:46978.
  • 22
    Honda K, Arima M, Cheng G et al. Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine. J Exp Med 2003; 198:53343.
  • 23
    Fujitani Y, Kanaoka Y, Aritake K, Uodome N, Okazaki-Hatake K, Urade Y. Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. J Immunol 2002; 168:4439.
  • 24
    Spik I, Brenuchon C, Angeli V et al. Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse. J Immunol 2005; 174:37038.
  • 25
    Narita S, Asakura K, Kataura A. Effects of thromboxane A2 receptor antagonist (Bay u 3405) on nasal symptoms after antigen challenge in sensitized guinea pigs. Int Arch Allergy Immunol 1996; 109:1616.
  • 26
    Nagai H, Takeda H, Yamaguchi S, Tanaka H, Matsuo A, Inagaki N. The effect of a thromboxane A2 receptor antagonist BAY-u-3405 on experimental allergic reactions. Prostaglandins 1995; 50:7587.
  • 27
    Takeshita K, Yamasaki T, Nagao K, Sugimoto H, Shichijo M, Gantner F, Bacon KB. CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation. Int Immunol 2004; 16:94759.
  • 28
    Huang JL, Gao PS, Mathias RA et al. Sequence variants of the gene encoding chemoattractant receptor expressed on Th2 cells (CRTH2) are associated with asthma and differentially influence mRNA stability. Hum Mol General 2004; 13:26917.
  • 29
    Oguma T, Palmer LJ, Birben E, Sonna LA, Asano K, Lilly CM. Role of prostanoid DP receptor variants in susceptibility to asthma. N Engl J Med 2005; 351:175263.
  • 30
    Hammad H, Jan de Heer H, Soullie T, Hoogsteden HC, Trottein F, Lambrecht BN. Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of D prostanoid receptor 1. J Immunol 2003; 171:393640.
  • 31
    Gosset P, Pichavant M, Faveeuw C, Bureau F, Tonnel AB, Trottein F. Prostaglandin D2 affects the differentiation and functions of human dendritic cells. impact on T cell response. Eur J Immunol 2005; 35:1491500.